These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16267249)

  • 1. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.
    Leaf A; Albert CM; Josephson M; Steinhaus D; Kluger J; Kang JX; Cox B; Zhang H; Schoenfeld D;
    Circulation; 2005 Nov; 112(18):2762-8. PubMed ID: 16267249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.
    Raitt MH; Connor WE; Morris C; Kron J; Halperin B; Chugh SS; McClelland J; Cook J; MacMurdy K; Swenson R; Connor SL; Gerhard G; Kraemer DF; Oseran D; Marchant C; Calhoun D; Shnider R; McAnulty J
    JAMA; 2005 Jun; 293(23):2884-91. PubMed ID: 15956633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of fish oil in arrhythmia prevention.
    Anand RG; Alkadri M; Lavie CJ; Milani RV
    J Cardiopulm Rehabil Prev; 2008; 28(2):92-8. PubMed ID: 18360184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial.
    Brouwer IA; Zock PL; Camm AJ; Böcker D; Hauer RN; Wever EF; Dullemeijer C; Ronden JE; Katan MB; Lubinski A; Buschler H; Schouten EG;
    JAMA; 2006 Jun; 295(22):2613-9. PubMed ID: 16772624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of coronary artery disease with omega-3 fatty acids.
    Jacobson TA
    Am J Cardiol; 2006 Aug; 98(4A):61i-70i. PubMed ID: 16919518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
    Christensen JH
    Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients.
    Stuber T; Eigenmann C; Delacrétaz E
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):702-7. PubMed ID: 16008807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy.
    Metcalf RG; Sanders P; James MJ; Cleland LG; Young GD
    Am J Cardiol; 2008 Mar; 101(6):758-61. PubMed ID: 18328835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
    Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
    Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators.
    Christensen JH; Riahi S; Schmidt EB; Mølgaard H; Kirstein Pedersen A; Heath F; Cosedis Nielsen J; Toft E
    Europace; 2005 Jul; 7(4):338-44. PubMed ID: 15944091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S27-9. PubMed ID: 17876194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial.
    Singer P; Wirth M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):153-9. PubMed ID: 15253884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
    Wilkoff BL; Ousdigian KT; Sterns LD; Wang ZJ; Wilson RD; Morgan JM;
    J Am Coll Cardiol; 2006 Jul; 48(2):330-9. PubMed ID: 16843184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure.
    Wilhelm M; Tobias R; Asskali F; Kraehner R; Kuly S; Klinghammer L; Boehles H; Daniel WG
    Am Heart J; 2008 Jun; 155(6):971-7. PubMed ID: 18513506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.